NCT00690638

Safety and Efficacy Study of Dutogliptin/PHX1149T to Treat Type 2 Diabetes Mellitus

A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate Safety and Efficacy of PHX1149T as Monotherapy in Subjects With Type 2 Diabetes Mellitus

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 480 (estimated)
• Sponsor: Phenomix · Industry
• Sex: All
• Age: 18 Years – 85 Years
• Healthy volunteers: Not accepted

Summary

A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate Safety and Efficacy of PHX1149T as Monotherapy in Subjects with Type 2 Diabetes Mellitus

Conditions

• Type 2 Diabetes Mellitus

Interventions

Type	Name	Description
DRUG	PHX1149T	200 mg
DRUG	PHX1149T	400 mg
DRUG	Placebo	Placebo

Timeline

• Start date: 2008-07-01
• Primary completion: 2010-01-01
• Completion: 2010-04-01
• First posted: 2008-06-04
• Last updated: 2010-04-13

Locations

62 sites across 9 countries: United States, Argentina, India, Malaysia, Peru, Philippines, Romania, Thailand, Ukraine